Crown Aesthetics Creates “Gateway” Microneedling, Platelet-Rich Plasma PRP and Skin Biome Care Technology That Draws New Patients to Leading Physician-Directed Practices Around the World.

Become A Provider

Crown Aesthetics Creates “Gateway” Microneedling, Platelet-Rich Plasma, and Light-Activated Cream Innovations That Draw New Patients to Leading Physician-Directed Practices Around the World.

Become A Provider

Beauty expert Cheryl Kramer Kaye reviews SkinPen and shares why she loves the First FDA-cleared microneedling device.

Melissa Rogne

Virtual Event Success

Strategies to Deliver Big when Events Go Virtual

Ensuring Success with SkinPen Precision

Angela McDonald, Senior Director of Education and National Accounts

Ready your Practice to Reopen

with Yael Halass, MD, FACS

Jumpstarting Your
Practice After Lockdown

with Rich Castellano, MD

Watch More Videos


Crown Aesthetics products deliver rejuvenation and restoration to your patients. And your bottom line.

SkinPen by Crown Aesthetics


The First FDA-Cleared Microneedling
Device in the World1

SkinPen by Crown Aesthetics


Breakthrough skin science that optimizes skin health on and below the surface.

ProGen PRP by Crown Aesthetics


Flexible Platelet-Rich Plasma System2


Become A Provider
[1] SkinPen® U.S. intended use: The SkinPen® Precision system is a microneedling device and accessories intended to be used as a treatment to improve the appearance of wrinkles of the neck for Fitzpatrick skin types II – IV and to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types aged 22 years and older. Rx only. SkinPen® international intended use: SkinPen Precision is a microneedling device that utilizes collagen induction therapy to treat melasma, acne, and surgical scars. See intended use, important safety information, and clinical trial details (data on file) at [2] ProGen™ intended use: The ProGen PC Kit is indicated for the rapid preparation of autologous Platelet Rich Plasma from a small sample of blood at the patient’s point of care. The Platelet Rich Plasma is mixed with autograft/or allograft bone prior to the application to a bony defect for improving handling characteristics of the graft. Results based on a survey conducted by patients after three procedures spaced four weeks apart.